{"created":"2023-07-27T06:28:48.765941+00:00","id":13385,"links":{},"metadata":{"_buckets":{"deposit":"2f7ac484-741f-4cb3-8329-6203fc93d6d1"},"_deposit":{"created_by":3,"id":"13385","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"13385"},"status":"published"},"_oai":{"id":"oai:kanazawa-u.repo.nii.ac.jp:00013385","sets":["1132:1133:1134"]},"author_link":["21881","21885","21882","210","21883","21884","21880"],"item_4_biblio_info_8":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2009-01-01","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"7","bibliographicPageEnd":"572","bibliographicPageStart":"569","bibliographicVolumeNumber":"48","bibliographic_titles":[{"bibliographic_title":"Internal Medicine"}]}]},"item_4_description_21":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Polyethylene glycol-interferon ﾎｱ (PEG-IFNﾎｱ) has been used as the standard treatment for hepatitis C virus (HCV) infection. There have been no previous reports of polyradiculoneuropathy with anti-ganglioside antibodies induced by PEG-IFNﾎｱ-2b. We report a 59-year-old man who developed polyradiculoneuropathy during treatment with PEG-IFN ﾎｱ-2b for chronic HCV infection. Serum levels of anti-asialo-GM1 (GA1) and anti-GM1 antibodies were elevated. Cessation of therapy with double filtration plasmapheresis resulted in marked improvement in his symptoms accompanied by a reduction in the antibody level. PEG-IFN ﾎｱ-2b may induce peripheral neuropathy mediated by anti-GA1 and anti-GM1 antibodies. © 2009 The Japanese Society of Internal Medicine.","subitem_description_type":"Abstract"}]},"item_4_description_5":{"attribute_name":"提供者所属","attribute_value_mlt":[{"subitem_description":"金沢大学医薬保健研究域医学系","subitem_description_type":"Other"}]},"item_4_publisher_17":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"The Japanese Society of Internal Medicine = 日本内科学会"}]},"item_4_relation_12":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"10.2169/internalmedicine.48.1794","subitem_relation_type_select":"DOI"}}]},"item_4_relation_28":{"attribute_name":"関連URI","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"http://www.jstage.jst.go.jp/article/internalmedicine/48/7/48_569/_article","subitem_relation_type_select":"URI"}},{"subitem_relation_type_id":{"subitem_relation_type_id_text":"http://www.naika.or.jp/","subitem_relation_type_select":"URI"}}]},"item_4_rights_23":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"Copyright (c) 2009 by The Japanese Society of Internal Medicine"}]},"item_4_source_id_11":{"attribute_name":"NCID","attribute_value_mlt":[{"subitem_source_identifier":"AA11211604","subitem_source_identifier_type":"NCID"}]},"item_4_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"1080-6040","subitem_source_identifier_type":"ISSN"}]},"item_4_version_type_25":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Kato-Motozaki, Yuko"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Koma, Kiyonobu"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Takahashi, Kazuya"}],"nameIdentifiers":[{},{}]},{"creatorNames":[{"creatorName":"Ishida, Chiho"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Ueda, Masami"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Kusunoki, Susumu"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Yamada, Masahito"}],"nameIdentifiers":[{},{},{},{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2017-10-03"}],"displaytype":"detail","filename":"AA11211604-2009-569.pdf","filesize":[{"value":"360.5 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"AA11211604-2009-569.pdf","url":"https://kanazawa-u.repo.nii.ac.jp/record/13385/files/AA11211604-2009-569.pdf"},"version_id":"c7373305-2136-49d1-8391-63b945a9956a"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Polyethylene Glycol Interferon α-2b-induced Immune-mediated Polyradiculoneuropathy","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Polyethylene Glycol Interferon α-2b-induced Immune-mediated Polyradiculoneuropathy"}]},"item_type_id":"4","owner":"3","path":["1134"],"pubdate":{"attribute_name":"公開日","attribute_value":"2017-10-03"},"publish_date":"2017-10-03","publish_status":"0","recid":"13385","relation_version_is_last":true,"title":["Polyethylene Glycol Interferon α-2b-induced Immune-mediated Polyradiculoneuropathy"],"weko_creator_id":"3","weko_shared_id":-1},"updated":"2023-07-28T01:06:01.582551+00:00"}